June 14 -17, 2018
Stockholm, Sweden
Mission Bio is pleased to announce an oral presentation from Dr. Christine McMahon, University of Pennsylvania, utilizing results from our Tapestri™ Platform:
Ras Mutations Are The Dominant Mechanism Of Secondary Resistance To Gilteritinib Therapy For Relapsed/Refractory Flt3-Mutated AML
Topic: Acute myeloid leukemia – Biology & Translational Research
Session Title: AML Biology & Translational Research II: Signaling
Final Abstract Code: S817
Saturday, June 16
12:30 – 12:45pm
Room A4
Dennis Eastburn, Ph.D., CSO Mission Bio will also be presenting a poster and a poster pitch presentation:
Single-cell DNA Analysis Of Mutational Heterogeneity In Acute Myeloid Leukemia Tumors With High-throughput Droplet Microfluidics
Topic: Acute myeloid leukemia – Biology & Translational Research
Session Title: Acute myeloid leukemia – Biology & Translational Research
Final Abstract Code: PS971
Saturday, June 16
5:30 – 7:00pm
Poster Area
Poster pitch presentation:
Session title: AML Biology & Translational Research II: Signalling
Date: Saturday, June 16
Time: 12:00 – 12:15
Location: Room A4
